Elena-Rodica M. Vasilescu, MD

Accepting New Patients

Profile Navigation

Overview
Schedule an Appointment
Research

Overview

Email: erv1@cumc.columbia.edu

Academic Appointments

Assistant Professor of Pathology & Cell Biology at CUMC

Administrative Titles

Associate Director, Immunogenetics and Clinical Immunology Laboratory

Gender

Female

Schedule an Appointment

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.
Connect Sign In

Research

Selected Publications

1. Polymorphism of HLA in the Romanian Population. Tissue Antigens 39:8- 13,1992(Reed,E;Ho,E;Lupu,F;McManus,P;Vasilescu,R;Foca-Rodi,A and Suciu-Foca,N)
2.Detection of T Suppressor Cells in Patients with Organ Allografts. Hum.Immunol, 62:15-20,2001.(Ciubotariu,R: Vasilescu R; ;Ho,E; Cinti ,P;Cancedda,C;..Suciu-Foca,N)
3. Indirect Allorecognition in Heart Allograft Rejection. Transplantation Proceedings, 33:(1-2) 2001(Ciubotariu,R; Liu,Z; Ho,E; Vasilescu,R ...Suciu-Foca,N)
4. Acute and Hyperacute Humoral Rejection in Kidney Allograft Recipients Treared with Anti-Human Tymocyte Antibodies Human Immunology 66,501-512(2005) Colovai,A; Vasilescu,R; ...Suciu-Foca,N)
5. Alloantibodies and Outcome of Cadaver Kidney Allograft.Human Immunology 67,597-604(2006) Vasilescu,R; Ho,E; Colovai A; Hardt, M; Ratner,L; suciu-Foca,N)
6. Polymorphism and linkage dosequilibrium of Immunoglobulin-like transcript 3 gene.Human Immunology02/2008(Chin-Chao Ch; Vlad,G Suciu-Foca,N; Vasilescu,R)
7. Sensitivity, Specificity and Clinical Relevance of Different Cross-Matching Assays In Deceased -Donor Renal Transplantation.Transpl. Immunol.2008 Nov:20(1-2).61-7(Ho,E;Vasilescu ,R; Colovai,A .. Cohen D; Ratner,L;Suciu-Foca,N)
8. Comparative outcome analysis of ABO- Incompatible and Positive Crossmatch Renal Transplant: a single-center experience. Transplantation 2009 Jun 27:87(Padmanabhan A; Ratner,L; Vasilescu,R; ....Schwartz,J)
9.Membrane and soluble ILT3 are critical to the generation of T suppressot cells and induction of Immunological Tolerance.Int.Rev Immunol.2010 Apr:29(2);
10. New-onset Graft Dysfunction after Heart Transplantation-incidence and mechanism-related outcoms.J Heart Transplant.2011Feb:30(2):194(Shahzad,K Aziz QA; Leva JP; Ho E; Vasilescu R; Latiff F Mancini D; Deng ,M)
11. Pre-and PostTransplantattion allosensitization in Heart Allograft Recipients:Major Impact of de novo alloantibody production on allograft survival Human Immunology 2010(Ho,E;Vlad,G; Vasilescu R; Colovai A; ...Suciu-Foca,N)
12. The Effect of Timing and Graft Dysfunction on Survival and Cardiac Vasculopathy an Antibody-Mediated Rejection> J.Heart Lung Transplant.2016(Sep;35(9) Clerkin K; Restaino S; Zorn E, Vasilescu R; Marboe C; Mancini D)
13.Molecular and Cellular Characterzation of Human CD8 T Suppressor Cells Front Immunol.2016Nov 30;7:549(Xu Z; Ho,S; Chang C; Zhang Q; Vasilescu R; Vlad G; Suciu-Foca N)
14. Donor-Specific Anti_HLA Antibodies with Antibody-Mediated Rejection and Long-Term outcomes following Heart Transplantation. J Heart Lung Transplant 2017 May:36(5) (Clerin K; Farr MA; Restaino S; Zorn E; Latif F; Vasilescu R; Marboe C; Colombo P; Mancini D)
15. Ventricular assist device Elicits serum natural IgG that Correlates with the Development of Primary Graft Dysfunction following Heart Transplantation.J Heart Lung Transplant 2017 Mar 24.( see S; Clerkin K; Kennel P; Zhang F; ...Vasilescu R; Vald G; ..Zorn E)